| Name | Animalcare Group |
|---|---|
| Epic | ANCR |
| Isin | GB0032350695 |
| Index | MID300 |
| Industry | Pharmaceuticals & Biotechnology |
| Latest share price | 243.00p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £146.71 | Debt ratio | n/a |
| Shares in issue | 60.37 | Debt-to-equity ratio | n/a |
| P/E ratio | 15.6 | Assets / equity ratio | n/a |
| Total dividends per share | 5.00p | Price to book value | n/a |
| Dividend yield | 2.9 | ROCE | 25.54 |
| Dividend cover | 2.18 | EPS growth | -14 |
| Earning per share | 2 | 52-week high / low | 166.40p / 284.00p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| Final | 2024-06-20 | 2024-07-19 | 3.00p |
| Interim | 2023-10-19 | 2023-11-17 | 2.00p |
| Final | 2023-06-15 | 2023-07-14 | 2.40p |
| Interim | 2022-10-20 | 2022-11-18 | 2.00p |
| Final | 2022-06-09 | 2022-07-08 | 2.40p |
| Interim | 2021-10-21 | 2021-11-19 | 2.00p |
| Final | 2021-06-03 | 2021-07-02 | 2.00p |
| Interim | 2020-10-22 | 2020-11-20 | 2.00p |
| Interim | 2019-10-24 | 2019-11-22 | 2.00p |
| Company name | Animalcare Group |
|---|---|
| Address | Animalcare, Moorside, Monks Cross, York, United Kingdom, YO32 9LB |
| Telephone | +44 (0) 1904 487687 |
| Website | http://www.animalcaregroup.com/ |
| Director | Position |
|---|---|
| Ms Jenny Winter | CEO |
| Mr Chris Brewster | CFO |
| Mr Marc Coucke | Non-Executive Director |
| Mr Jan Boone | Non-Executive Chairman |
| Mr Edwin (Ed) Torr | Senior Independent Non-Executive Director |
| Dr Douglas Hutchens | Independent Non-Executive Director |
| Mr Sylvia Metayer | Independent Non-Executive Director |
| Assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 31/12/23 | 31/12/22 | 31/12/21 |
| Intangible asssets and goodwill | 71.24 | 76.14 | 80.55 |
| Investments and other non-current assets | 1.12 | 1.3 | 1.29 |
| Total non-current assets | 77.38 | 84.45 | 85.71 |
| Inventory / work in progress | 10.06 | 13.47 | 10.33 |
| Trade and other receivables | 13.29 | 13.57 | 7.14 |
| Cash and equivalents | 4.64 | 6.04 | 5.63 |
| Other current assets and asset held for resale | 1.42 | 0.71 | 1.2 |
| Total of all assets | 106.79 | 118.24 | 110 |
| Liabilities £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 18.42 | 22.28 | 14.45 |
| Long term liabilities | 10.48 | 16.98 | 16.75 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 28.9 | 39.26 | 31.2 |
| Net assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 77.89 | 78.99 | 78.8 |
| Equity £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | 12.02 | 12.02 | 12.02 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | -12.78 | -11.98 | -11.68 |
| Share premium account | 132.8 | 132.8 | 132.8 |
| Total equity | 77.89 | 78.99 | 78.8 |
| Income £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | 4.41 | 3.24 | 1.99 |
| Pre-tax profit | 3.52 | 2.54 | 0.94 |